Advocacy Hub | CNSF Members

Updates & Recommendations

from HEALTH CANADA - Marketed Health Products Directorate

10 October 2023

Re: topiramate use in women of childbearing potential

Topiramate is already known to cause serious birth defects when used during pregnancy; safety information is already included in the Canadian label. However, further to recently available data and international regulatory activities, we would like to request feedback from CSCN, CACN and the CNS societies on risk minimization measures (RMMs) for topiramate use in women of childbearing potential to mitigate the potential risk of fetal harm.

Health Canada is seeking your clinical input on the following:

  1. Do you consider that labelling alone is sufficient to manage the risk of fetal
    malformation/NDD for topiramate, or is there a need for additional RMMs to mitigate the
    1. If yes, please provide your views as to the type of measures recommended (e.g. educational materials).
  2. Whether a PPP is needed to enforce the instructions for use in the CPM and ensure that the
    risk of fetal malformations/NDD associated with the use of topiramate during pregnancy
    are properly mitigated.
    1. If yes, please provide your recommended elements of the PPP.
  3. Please provide comments on the feasibility and possible impact of the recommended
    measures on clinical practice, clinical workflow and patient impact as deemed applicable.
  4. Please provide your views on the potential addition of a contraindication regarding the use
    of topiramate for the management of epilepsy unless there is no suitable alternative.
  5. Please provide any additional comments you have on this issue.

Please direct your response by email to your society Advocacy Committee representative before October 25, 2023.

Linda Magnusson / CNS

Steve Baker / CSCN

Michael Esser / CACN 

from the CNSF and Canadian Blood Services (CBS)

15 June 2023

IVIG Donation Challenge

The CNSF is participating at the policy level with Canadian Blood Services (CBS) to address priorities around IVIG supply and distribution. There is a rising use of IVIG as an immune therapy for multiple neurological diseases, both adult and pediatric. Giving plasma (for IVIG) is a way for each of us to directly give back and get involved in the care of our patients.

We want the CSNF members to BE THE SOLUTION, meet the Challenge!

practicing physicians VS residents/students/fellows/affiliate society members

  • Which group can have more folks giving one or more donations in the next year?

  • Click on the QR code applicable to your group, provide contact information and then CBS will follow-up with you in your home city.

  • CBS will keep track of who donates and we will review this again next year to see who wins!

  • There will be a Special prize (TBD) awarded to the donor who provides the most plasma over 1 year.

CBS Plasma Toolkit - Become a plasma donor

Practicing physicians - Full Member Team

Sign in or create an account | MyAccount (

Residents/Students/Fellows/affiliates -  Associate Member Team

Sign in or create an account | MyAccount (


from the Association of Medical Microbiology and Infectious Disease (AMMI) Canada’s Clinical Research Network (CRN)

21 June 2023

Recently, a global call to action to reduce inappropriate antimicrobial use was made because of the growing concern of emerging antimicrobial resistance and lack of new drugs to treat drug-resistant infections. Inappropriate antibiotic use is common and an important driver of antibiotic resistance. However, a variety of factors contribute to the difficulty in using antibiotics appropriately. Because of the diversity of influencing factors on prescriber behavior, successful hospital antimicrobial stewardship programs (ASPs) are multifaceted with an emphasis on prospective audit and feedback (PAF) interventions, a recommended strategy to assist clinicians in optimizing antimicrobial use.

In order to study which interventions may be effective stewardship interventions, baseline prescribing practices need to be studied first.   As such, a group of investigators created a survey to gather antimicrobial prescribing practices in adults in acute care settings.   We are interested in your management and choice of antibiotic in a selection of clinical scenarios.

We invite all clinicians, medical students, post graduate trainees, attending MDs, nurse practitioners, pharmacists etc. whose practice may involve reviewing microbiology result reports and use these to inform patient management and antibiotic selection to complete the survey.  The survey will take approximately 10 minutes.  By completing the survey, you are consenting to participate in the study.

Your responses are for research purposes only and your participation in voluntary.  There are no risks associated with participating in this study.  This study has been funded by the St. Michael’s Hospital AFP Innovation Fund, who has no role in the study design or analysis.

To participate in the survey, please CLICK HERE

from HEALTH CANADA - Proactive Risk Management Projects / Projets de gestion proactive des risques (HC/SC)

02 December 2022

Raising Awareness – Avoiding Unauthorized Health Products Online (presentation materials)

Sensibilisation – Éviter les produits de santé non autorisés en ligne (matériel de présentation)

The presentation slides can be reviewed by health care professionals at their convenience. Health care professionals are also encouraged to put the handout up at their office or disseminate physical or electronic copies to their clients/patients. The handout speaks to the risks of buying health products online and avoiding unauthorized health products. It also summarizes a list of resources on Health Canada’s webpages.

from the CNSF Advocacy Committee

06 June 2022

The CNSF is contacting you urgently with respect to an immediate and ongoing shortage of intravenous iodinated contrast (radio-contrast media) in Canada.

from the Canadian League Against Epilepsy (CLAE)

16 April 2021

The Canadian League Against Epilepsy is currently working with Health Canada’s Drug Shortages Unit to determine the impact of Apotex and JAMP’s extended shortage on Oxcarbazepine supply.

from the Canadian Stroke Consortium (CSC)

8 May 2021

What should we do as neurologists?

Disseminate this information to your trainees, and neurology colleagues to spread awareness with respect to recognizing this entity and the distinct treatment strategy for this condition.